Likewise, TRYP was found to be effective in protecting mice against experimentally-induced colitis via regulation of the tumor necrosis factor (TNF)/nuclear factor (NF)-κB and interleukin (IL)-6/signal transducer and activator of transcription 3 (STAT3) signaling pathways (Wang et al., 2018). Here, TNF is linked to colitis.